141 related articles for article (PubMed ID: 11564695)
1. Evidence that anabolic effects of PTH on bone require IGF-I in growing mice.
Miyakoshi N; Kasukawa Y; Linkhart TA; Baylink DJ; Mohan S
Endocrinology; 2001 Oct; 142(10):4349-56. PubMed ID: 11564695
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.
Bikle DD; Sakata T; Leary C; Elalieh H; Ginzinger D; Rosen CJ; Beamer W; Majumdar S; Halloran BP
J Bone Miner Res; 2002 Sep; 17(9):1570-8. PubMed ID: 12211426
[TBL] [Abstract][Full Text] [Related]
3. Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice.
Yamaguchi M; Ogata N; Shinoda Y; Akune T; Kamekura S; Terauchi Y; Kadowaki T; Hoshi K; Chung UI; Nakamura K; Kawaguchi H
Endocrinology; 2005 Jun; 146(6):2620-8. PubMed ID: 15718274
[TBL] [Abstract][Full Text] [Related]
4. In vivo anabolic effects of parathyroid hormone (PTH) 28-48 and N-terminal fragments of PTH and PTH-related protein on neonatal mouse bones.
Rihani-Bisharat S; Maor G; Lewinson D
Endocrinology; 1998 Mar; 139(3):974-81. PubMed ID: 9492028
[TBL] [Abstract][Full Text] [Related]
5. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1.
Bodine PV; Seestaller-Wehr L; Kharode YP; Bex FJ; Komm BS
J Cell Physiol; 2007 Feb; 210(2):352-7. PubMed ID: 17044082
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy-associated plasma protein-A modulates the anabolic effects of parathyroid hormone in mouse bone.
Clifton KB; Conover CA
Bone; 2015 Dec; 81():413-416. PubMed ID: 26297833
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone.
Pfeilschifter J; Laukhuf F; Müller-Beckmann B; Blum WF; Pfister T; Ziegler R
J Clin Invest; 1995 Aug; 96(2):767-74. PubMed ID: 7635970
[TBL] [Abstract][Full Text] [Related]
8. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone.
Schneider MR; Dahlhoff M; Andrukhova O; Grill J; Glösmann M; Schüler C; Weber K; Wolf E; Erben RG
Bone; 2012 Jan; 50(1):237-44. PubMed ID: 22056328
[TBL] [Abstract][Full Text] [Related]
9. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.
Hirano T; Burr DB; Turner CH; Sato M; Cain RL; Hock JM
J Bone Miner Res; 1999 Apr; 14(4):536-45. PubMed ID: 10234574
[TBL] [Abstract][Full Text] [Related]
10. Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism.
Miyakoshi N; Qin X; Kasukawa Y; Richman C; Srivastava AK; Baylink DJ; Mohan S
Endocrinology; 2001 Jun; 142(6):2641-8. PubMed ID: 11356715
[TBL] [Abstract][Full Text] [Related]
11. Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice.
Hurley MM; Okada Y; Xiao L; Tanaka Y; Ito M; Okimoto N; Nakamura T; Rosen CJ; Doetschman T; Coffin JD
Biochem Biophys Res Commun; 2006 Mar; 341(4):989-94. PubMed ID: 16455048
[TBL] [Abstract][Full Text] [Related]
12. Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone.
Pettway GJ; Schneider A; Koh AJ; Widjaja E; Morris MD; Meganck JA; Goldstein SA; McCauley LK
Bone; 2005 Jun; 36(6):959-70. PubMed ID: 15878317
[TBL] [Abstract][Full Text] [Related]
13. Inhibited anabolic effect of insulin-like growth factor-I on stromal bone marrow cells in endothelial nitric oxide synthase-knockout mice.
Lagumdzija A; Ou G; Petersson M; Bucht E; Gonon A; Pernow Y
Acta Physiol Scand; 2004 Sep; 182(1):29-35. PubMed ID: 15329054
[TBL] [Abstract][Full Text] [Related]
14. Comparison of bone formation responses to parathyroid hormone(1-34), (1-31), and (2-34) in mice.
Mohan S; Kutilek S; Zhang C; Shen HG; Kodama Y; Srivastava AK; Wergedal JE; Beamer WG; Baylink DJ
Bone; 2000 Oct; 27(4):471-8. PubMed ID: 11033441
[TBL] [Abstract][Full Text] [Related]
15. The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone.
Yakar S; Bouxsein ML; Canalis E; Sun H; Glatt V; Gundberg C; Cohen P; Hwang D; Boisclair Y; Leroith D; Rosen CJ
J Endocrinol; 2006 May; 189(2):289-99. PubMed ID: 16648296
[TBL] [Abstract][Full Text] [Related]
16. Skeletal unloading alleviates the anabolic action of intermittent PTH(1-34) in mouse tibia in association with inhibition of PTH-induced increase in c-fos mRNA in bone marrow cells.
Tanaka S; Sakai A; Tanaka M; Otomo H; Okimoto N; Sakata T; Nakamura T
J Bone Miner Res; 2004 Nov; 19(11):1813-20. PubMed ID: 15476581
[TBL] [Abstract][Full Text] [Related]
17. Role of IGF-I on PTH effects on bone.
Lombardi G; Di Somma C; Vuolo L; Guerra E; Scarano E; Colao A
J Endocrinol Invest; 2010; 33(7 Suppl):22-6. PubMed ID: 20938222
[TBL] [Abstract][Full Text] [Related]
18. Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats.
Hock JM; Gera I; Fonseca J; Raisz LG
Endocrinology; 1988 Jun; 122(6):2899-904. PubMed ID: 3371266
[TBL] [Abstract][Full Text] [Related]
19. The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice.
Yamane H; Sakai A; Mori T; Tanaka S; Moridera K; Nakamura T
Bone; 2009 Jun; 44(6):1055-62. PubMed ID: 19303837
[TBL] [Abstract][Full Text] [Related]
20. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
Oxlund H; Ortoft G; Thomsen JS; Danielsen CC; Ejersted C; Andreassen TT
Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
